Provides clinics and clinicians with brain-activity assessment equipment, analysis software, and clinical reports.
10-K for FY2025, filed Mar 31, 2026We have built the Firefly Platform: a vertically integrated hardware, software, and data infrastructure that captures standardized…View ↗
Our FDA-510(k) cleared Evoke System, commercially deployed as the Evoke System, is in active use across more than 85 clinical sites in the…View ↗
The Evoke System is our FDA-510(k) cleared EEG and ERP acquisition hardware and associated software, deployed in clinical settings across…View ↗
Clinics pay monthly for access to the platform, equipment and a set number of assessments; extra scans are charged per use. The company also earns from equipment sales and rentals, projects, clinical studies and related services.
10-K for FY2025, filed Mar 31, 2026We sell access to the Firefly Platform through a tiered subscription model. Clinics pay a monthly subscription fee that provides access to…View ↗
Revenue consists of subscriptions with associated equipment, per-use fees, equipment sales, equipment rentals, and the undertaking of…View ↗
The Company offerings are assessed to determine whether an embedded lease arrangement exists. Revenues from equipment rentals and…View ↗
10-K for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$1.1M
10-K for FY2025, filed Mar 31, 2026
$1.1M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Service
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
71% |
Service, FY2025
$814K Sources
|
Sold outright |
|
Rentals
Mix
|
6.5% |
Rentals, FY2025
$74K Sources
|
Mix |
|
Product
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
9.7% |
Product, FY2025
$111K Sources
|
Sold outright |
|
Subscription and Circulation
Recurring
10-K for FY2025, filed Mar 31, 2026 |
9.6% |
Subscription and Circulation, FY2025
$110K Sources
|
Recurring |
|
Product and Service, Other
|
2.9% |
Product and Service, Other, FY2025
$33K Sources
|
The company serves individual practitioners, multi-provider clinics and health systems. Clinicians use the system for patient assessments and receive reports through a cloud portal.
10-K for FY2025, filed Mar 31, 2026Multiple subscription tiers are available to accommodate the diverse utilization profiles of our clinical customers; from individual…View ↗
Our FDA-510(k) cleared Evoke System, commercially deployed as the Evoke System, is in active use across more than 85 clinical sites in the…View ↗
The output of this analysis is a structured clinical report delivered to the clinician. This report contextualizes the patient's…View ↗
No. It lost $19.9M in FY2025.
10-Q for Q2 FY2026, filed Aug 11, 2026
−$2MView ↗
10-Q for Q2 FY2026, filed Aug 11, 2026
Open tableView ↗
8-K, filed Sep 14, 2026
On September 8, 2026, the board of directors (the “Board”) of Firefly Neuroscience, Inc., a Delaware corporation (the “Company”)…View ↗
Shrinking. Revenue fell 92% in 4 years, from $15M in FY2021 to $1.1M in FY2025, about 48% a year.
From IT services to brain assessment
The business moved from IT consulting, legacy-software modernization, cybersecurity and supply-chain software to brain-activity assessment equipment, analysis software and clinician reports.
10-K for FY2022, filed Apr 17, 2023 10-K for FY2025, filed Mar 31, 2026As a trusted partner, Tellenger offers a full suite of IT services including consulting, development, training, migration and modernization…View ↗
While we offer a range of services, historically, two areas of focus for us have been modernization, including cloud services and…View ↗
Tellenger specializes in cybersecurity by leveraging its resources within software development and cloud services, and took part in…View ↗
With our purchase of Gray Matters we acquired a U.S. government contract to provide a cloud based software platform for tracking, auditing…View ↗
Loading...